Skip to main content Deutsch

News

New findings in treatment of KRAS-mutated colorectal cancer - Study reveals surprising role for the Epidermal Growth Factor Receptor (EGFR)

University, Medicine & Science

KRAS mutations are among the most common genetic alterations in cancer and are considered particularly difficult to treat. In colon cancer, the second…

Juliane Winkler Honored with Johann Wilhelm Ritter von Mannagetta Prize for Medicine for Breakthroughs in Metastasis Research

People of the MedUni Vienna

Juliane Winkler, a researcher at the Center for Cancer Research at the Medical University of Vienna, has been awarded the Johann Wilhelm Ritter von…

New therapeutic approach for aggressive type of brain tumor

Diffuse hemispheric glioma (DHG) is a brain tumor in children, adolescents and young adults with an average survival prognosis of less than two years…

IMMOX'25 - Best Poster Award

Medicine & Science, People of the MedUni Vienna

Award in Oxford for Regina Jin from the Centre for Cancer Research for the best poster

Breast cancer research: a matter of age

Medicine & Science

A new study published in Cell Death & Differentiation and co-lead by researchers at the Medical University of Vienna and the European Institute of…

Presentation success at the ÖGDV Science Days

Medicine & Science, People of the MedUni Vienna

Regina Jin from the Center for Cancer Research is awarded a talk prize

New combination immunotherapy for melanoma and breast cancer

Medicine & Science

A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer. This therapy…

Alfredo Cristiano De Sá Fernandes receive Award of Excellence

Alfredo Cristiano De Sá Fernandes and Georg Semmler have been presented with the Award of Excellence by the Ministry of Science for their outstanding…

Cancer therapy: New option for the treatment of permanent hair loss

Medicine & Science

As much as targeted therapy using so-called EGFR inhibitors has proven its worth for various types of tumours, possible side effects can be very…

Cancer Research Run 2024: 270,000 euros for research

A total of around 3,900 runners, including numerous companies with running teams, as sponsors or cooperation partners, supported cancer research at…